adalimumab EFab
Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage
| Chains | Domain Info | Class | Fold | Superfamily | Family | Domain | Species | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| B [auth H] | d6cr1h1 | All beta proteins | Immunoglobulin-like beta-sandwich | Immunoglobulin | automated matches | automated matches | (Homo sapiens ) [TaxId: 9606 ], | SCOPe (2.08) |
| B [auth H] | d6cr1h3 | Artifacts | Tags | Tags | Tags | C-terminal Tags | (Homo sapiens ) [TaxId: 9606 ], | SCOPe (2.08) |
| A [auth L] | d6cr1l1 | All beta proteins | Immunoglobulin-like beta-sandwich | Immunoglobulin | automated matches | automated matches | (Homo sapiens ) [TaxId: 9606 ], | SCOPe (2.08) |
Domain Annotation: ECOD Classification ECOD Database Homepage
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
|---|---|---|---|---|---|---|---|---|
| B [auth H] | Amidohydro_2 | e6cr1H1 | A: a/b three-layered sandwiches | X: PriB N-terminal domain-like | H: ADP-ribosylation | T: ADP-ribosylation | F: Amidohydro_2 | ECOD (v294.1) |
| A [auth L] | Amidohydro_2 | e6cr1L1 | A: a/b three-layered sandwiches | X: PriB N-terminal domain-like | H: ADP-ribosylation | T: ADP-ribosylation | F: Amidohydro_2 | ECOD (v294.1) |
Domain Annotation: CATH CATH Database Homepage
| Chain | Domain | Class | Architecture | Topology | Homology | Provenance Source (Version) |
|---|---|---|---|---|---|---|
| B [auth H] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (utative) |
| A [auth L] | 2.60.40.10 | Mainly Beta | Sandwich | Immunoglobulin-like | Immunoglobulins | CATH (4.3.0) |
IMGT Antibody Annotation IMGT Database Homepage
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|---|---|---|---|---|---|---|---|
| B [auth H] | Efab adalimumab | VH-CH2 | Homo sapiens (human) | IGHV3-9*01, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGHE*01, IGHE*02, IGHE*04, IGHE*03 | V-DOMAIN VH, C-DOMAIN CH2 | IG | VH-CH2_V-KAPPA-CH2 | IMGT (202613-0) |
| A [auth L] | Efab adalimumab | V-KAPPA-CH2 | Homo sapiens (human) | IGKV1-27*01, IGKJ1*01, IGKJ2*01, IGHE*01, IGHE*02, IGHE*04, IGHE*03 | V-DOMAIN V-KAPPA, C-DOMAIN CH2 | IG | VH-CH2_V-KAPPA-CH2 | IMGT (202613-0) |
SAbDab Antibody Annotation SAbDab Database Homepage
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|---|---|---|---|---|
| B [auth H] | Heavy Chain | IGHV3 | - | - | SAbDab (2026-04-10) |
| A [auth L] | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-04-10) |
Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage
| Chain | Name | Target | Provenance Source |
|---|---|---|---|
| B [auth H] | Remtolumab | IL17A, TNF/TNFA | Therapeutic SAbDab (2026-04-10) |
| A [auth L] | Adalimumab | TNF/TNFA, IL17A | Therapeutic SAbDab (2026-04-10) |














